SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001842952-24-000046
Filing Date
2024-06-14
Accepted
2024-06-14 07:50:14
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718365807.html 4  
1 FORM 4 wk-form4_1718365807.xml 4 3994
  Complete submission text file 0001842952-24-000046.txt   5584
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Kantoff Philip W. (Reporting) CIK: 0001866025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 241043165